###begin article-title 0
###xml 148 153 <span type="species:ncbi:9606">human</span>
Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease
###end article-title 0
###begin p 1
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 344 347 <span type="species:ncbi:10116">rat</span>
###xml 356 359 <span type="species:ncbi:10116">rat</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 511 514 <span type="species:ncbi:10116">rat</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
###xml 862 867 <span type="species:ncbi:9606">human</span>
###xml 1185 1190 <span type="species:ncbi:9606">human</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
###xml 1938 1943 <span type="species:ncbi:9606">women</span>
Distinct luteinizing hormone receptor (LHR) protein variants exist due to the posttranslational modifications. Besides ovaries, LHR immunoreactivity (LHRI) was also found in other tissues, such as the brain, fallopian tube, endometrium, trophoblast and resident tissue macrophages. The 3B5 mouse monoclonal antibody was raised against purified rat LHR. In rat, porcine and human ovaries, the 3B5 identified six distinct LHR bands migrating at ~92, 80, 68, 59, 52 and 48 kDa. Characteristic LHRI was detected in rat, human and porcine corpora lutea. During cellular differentiation, subcellular LHR distribution changed from none to granular cytoplasmic, perinuclear, surface, nuclear and no staining. There were also differences in vascular LHR expression - lack of LHRI in ovarian vessels and strong staining of vessels in other tissues investigated. In normal human term placentae, villous LHRI was associated with blood sinusoids and cytotrophoblast cells, and rarely detected in trophoblastic syncytium. In all abnormal placentae, the LHRI of sinusoids was absent, and syncytium showed either enhanced (immature placental phenotypes) or no LHRI (aged placental phenotype). LHRI in human brain was identified in microglial cells (CD68+ resident macrophages). Protein extracts from human vaginal wall and levator ani muscle and fascia showed strong ~92 and 68 kDa species, and LHRI was detected in smooth muscle cells, fibroblasts, resident macrophages and nuclei of skeletal muscle fibers. Our observations indicate that, in contrast to the theory on the role of vascular hormone receptors in preferential pick up of circulating hormones, there is no need to enhance selective pick up rather only prevent LH/CG transport to inappropriate sites. Abnormal placental LHR expression may play a role in the development of abnormal pregnancy. Expression of LHR in the pelvic floor compartments suggests that high LH levels in postmenopausal women may contribute to the pelvic floor relaxation and increased incidence of pelvic floor disorders. Since chorionic gonadotropin increases secretion of a variety of cytokines by monocytes, and induces their inflammatory reaction and phagocytic activity, high LH levels in aging individuals may also activate microglia (mononuclear phagocyte system in the central nervous system) and contribute to the development of Alzheimer's disease and other inflammation-mediated neurodegenerative diseases.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
The luteinizing hormone receptor (LHR) plays a fundamental role in ovarian responsiveness to pituitary LH. The LHR consists of a 335 residue extracellular domain which contains six N-linked glycosylation sites [1]. Posttranslational changes in glycosylation and phosphorylation result in several LHR variants migrating between ~93 and 44 kDa [2-17]. Lower molecular weight forms (48 and 44 kDa species) appear to represent a glycosylated extracellular domain expressed in mammalian cells (truncated receptor) and retain hormone binding specificity. They are not secreted from cells, but remain trapped intracellularly [18]. In addition to various glycosylated LHR variants, western blotting also yielded a 170 kDa band representing an LHR dimer [19]. LH binds to LHR variants with different affinities, and highest affinity appears to be associated with the fully glycosylated receptor (~90 kDa) [19]. Chorionic gonadotropin (CG), which is important for corpus luteum (CL) rescue and maintenance of pregnancy, also binds to LHR, although with a 10-fold lower binding affinity compared with that of LH [20].
###end p 3
###begin p 4
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 15 18 <span type="species:ncbi:10116">rat</span>
###xml 92 95 <span type="species:ncbi:10116">rat</span>
###xml 148 151 <span type="species:ncbi:10116">rat</span>
###xml 364 367 <span type="species:ncbi:10116">rat</span>
The mouse anti-rat LHR monoclonal antibody (mAb), clone 3B5, was developed against purified rat LHR [21]. The antibody showed immunoreactivity with rat granulosa cells of mature (preovulatory) follicles, ovarian thecal and interstitial cells, granulosa-lutein cells of developing, mature and regressing CL, and with testicular Leydig cells, and no reactivity with rat kidneys [22]. During the last ten years, affinity purified 3B5 antibody has been used in several immunohistochemical studies [23-26]. To our knowledge, however, no analysis of the 3B5 antibody by western blot has been reported.
###end p 4
###begin p 5
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
In porcine ovaries, LHR expression was detected in granulosa and theca cells of preovulatory follicles, but not in granulosa lutein cells of the mature CL [27]. In human ovaries, LHR expression was also detected in granulosa and theca cells of preovulatory follicles, but mature CL showed strong expression in luteal cells, which disappeared during luteal regression. CL from early human pregnancies showed various intensities of LHR expression (from weak to intense) on the surface and in the cytoplasmic regions of luteal cells [24].
###end p 5
###begin p 6
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 273 276 <span type="species:ncbi:10116">rat</span>
###xml 292 295 <span type="species:ncbi:10116">rat</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
LHR expression was also detected in nonpregnant human uterus (glandular and luminal epithelial cells, stromal cells, myometrial cells and vascular smooth muscle cells), syncytiotrophoblast of midterm but not term human placenta, fetal membranes and decidua [28], human and rat brain [29,30], rat prostate [14,15], human trophoblast and syncytiotrophoblast from early pregnancies [31], porcine fallopian tubes and umbilical cord [16,32], ovarian, decidual, endometrial and luteal macrophages [22,33], and ovarian cancer cell cultures and tumor tissues [34].
###end p 6
###begin p 7
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 610 615 <span type="species:ncbi:9606">women</span>
Beside its involvement in the regulation of ovarian function, the LHR appears to be involved in some additional effects. LHR immunoreactivity in porcine fallopian tubes was confined to the epithelium and smooth muscle cells, and in vitro LH treatment caused relaxation of the oviduct [35]. Also, LHR stimulation plays a role in the induction and maintenance of myometrial quiescence [36-38]. Since smooth muscles belong among important compartments of the pelvic floor, high LH levels after menopause might be involved in the increased incidence of pelvic floor disorders, a common condition in postmenopausal women [39]. Since the brain was reported to express functional LHR [29,30], there is also a possibility that high LH levels in aging individuals may in some way participate in the development and progression of neurodegenerative process of several degenerative neurological diseases, including Alzheimer's disease.
###end p 7
###begin p 8
###xml 145 148 <span type="species:ncbi:10116">rat</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 340 343 <span type="species:ncbi:10116">rat</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
The aim of the present study was to investigate subcellular LHR distribution and determine LHR protein variants identified by 3B5 mAb in various rat, human and porcine tissues. During cellular differentiation, a transition from cytoplasmic to perinuclear, surface, nuclear and no LHR immunoreactivity was detected. In protein extracts from rat, porcine and human ovaries six distinct LHR bands were observed, migrating between ~92 and 48 kDa.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats
###end title 10
###begin p 11
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 185 189 <span type="species:ncbi:10116">rats</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
Rats of the CII-ZV strain, born and maintained in the Laboratory of Biology of Reproduction, Zaragoza, Mexico, were maintained on a 14L-10D cycle (lights on 0500-1900 h). The postnatal rats were weaned at 21 days of age, and they attained sexual maturity during the 6th week of life. Ovaries were studied in proestrous rats, at the age of two months. Daily vaginal smears were collected for about ten days prior to sacrifice.
###end p 11
###begin title 12
Porcine tissues
###end title 12
###begin p 13
Twenty porcine ovaries with fallopian tubes and some additional porcine tissues were obtained from a local abattoir and tissue samples were frozen within one hour. With respect to the follicular and luteal development, porcine ovaries were macroscopically classified as follows: Early/mid follicular - medium sized antral follicles (3-5 mm) accompanied by shrinking fibrous corpora lutea of similar size; late follicular - large antral follicles (>5 mm) not accompanied by any luteal tissue; early/ mid luteal - large corpora lutea (~10 mm) characterized by yellowish color; and late luteal - CL of diminishing size (~7 mm) with massive bleeding into the central cavity (bluish color) and no accompanying follicles.
###end p 13
###begin title 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tissues
###end title 14
###begin p 15
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">Human</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
Frozen blocks of human tissues from previous studies were obtained as described previously [40-44]. Some tissues also originated from the Cooperative Human Tissue Network, Columbus, Ohio. Functional stage of ovaries was classified according to the endometrial morphology [45]. Ovaries and endometrial samples were obtained from hysterectomy specimens. We also utilized frozen blocks and protein extracts from human placental chorionic villi, and protein extracts from trophoblast cultures and cultured amniotic fibroblasts and placental mononuclear cells [46]. Placental mononuclear cells were collected from the first digestion, which contains no trophoblast cells [46]. The study was approved by the Institutional Animal Care and Use Committee and Institutional Review Board.
###end p 15
###begin title 16
Tissue processing and peroxidase immunohistochemistry
###end title 16
###begin p 17
All chemicals, except where specified otherwise, were purchased from Sigma Chemical Co., St. Louis, MO. Tissue samples were collected into cryomold biopsy vinyl specimen molds (Tissue-Tek Cryomold Biopsy, Miles Inc. Diagnostic Division, Elkhart, IN) and embedded in an optimum cutting temperature formulation of water-soluble glycols and resins (O.C.T. compound; Miles). The molds with specimens were frozen by floating on liquid nitrogen and stored at -80degreesC until use. Frozen tissues were sliced into 7 mum serial sections using a cryostat microtome with specimen retraction during return travel (Carl Zeiss Microm HM 505 E; MICROM Laborgerate GmbH, Waldorf, Germany) and ten to twelve distinct tissue sections were placed on each slide. The slides were dried ~2 h at room temperature, fixed 5 min in acetone, dried 30 min, and stored at -80degreesC until immunoperoxidase staining was performed. Prior to staining, to prevent water condensation, the slides were transferred at -80degreesC into pre-chilled air protected boxes containing Drierite granules (W.A. Hammond Drierite Co, Ltd, Xenia, OH), and the boxes with slides were equilibrated to -20degreesC, +4 (cold room) and room temperature (20 min each step) before opening.
###end p 17
###begin p 18
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 217 222 <span type="species:ncbi:9823">swine</span>
###xml 228 233 <span type="species:ncbi:10090">mouse</span>
###xml 338 341 <span type="species:ncbi:10116">rat</span>
Slides were incubated overnight (cold room) with primary antibodies (see below). Specimens were then transferred to room temperature, extensively washed in freshly prepared PBS, pH 7.22, and incubated 20 minutes with swine anti-mouse IgG peroxidase conjugate (SwAM; SEVAC Praha, Prague, Czech Republic) diluted 1:20, and preabsorbed with rat kidney homogenate to remove nonspecific background [46]. Control slides were similarly processed, but primary antibody was replaced with PBS. Antigen-antibody complexes were detected by standard diaminobenzidine technique (brown color). Some slides were counterstained with hematoxylin, and all slides were dehydrated and mounted. Dual color immunohistochemistry experiments were performed as described previously [47].
###end p 18
###begin p 19
###xml 475 479 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 490 494 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Evaluation was performed on a Leitz DM RB (Leica Inc., Wetzlar, Germany) microscope equipped with differential interference contrast and a DEI-470 CCD Video Camera System (Optronics Engineering, Goleta, CA) with detail enhancement. The video images were captured by CG-7 color frame grabber (Scion Corporation, Frederick, MD) supported by Scion Image public software developed at the National Institutes of Health (Wayne Rasband, NIH, Bethesda, MD), and ported into Microsoft(R) Power-Point(R) 97 SR-2 (Microsoft Corporation, Redmont, WA).
###end p 19
###begin title 20
Primary antibodies
###end title 20
###begin p 21
###xml 156 158 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 159 161 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 371 373 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 512 514 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 551 553 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 778 780 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:9606">Child</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
###xml 528 531 <span type="species:ncbi:10116">rat</span>
###xml 815 820 <span type="species:ncbi:9606">Child</span>
For LHR immunohistochemistry, the 3B5 affinity purified antibody was used at 50 mug/ml. The antibody is IgG1 class, developed and characterized previously [21,22]. The antibody was stored at -80degreesC, either as a lyophylizate, or in diluted aliquots. For immunoblots, the antibody concentration was 10 mug/ml. We also used mouse anti-human Thy-1 mAb, clone F15-42-01 [48] (Dr. Rosemarie Dalchau, Institute of Child Health, London, UK), a marker of placental decidual cells (and fibroblasts and brain tissue) [46], mouse anti-rat Thy-1, clone OX-7 [49] (Dr Alan F. Williams, University of Oxford, Oxford, UK), mAbs against CD68, a marker of tissue macrophages, and CD14, a marker of monocytes (Dako Corporation, Carpinteria, CA), and leukocyte-common antigen, clone F10-89-4 [50] (Dr. John F. Fabre, Institute of Child Health, London, UK).
###end p 21
###begin title 22
Tissue extracts and western blot analysis
###end title 22
###begin p 23
###xml 484 486 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 46 51 <span type="species:ncbi:9606">human</span>
For preparation of protein extracts from rat, human and porcine tissues for western blot analysis, 150 cryostat tissue sections (7 mum) were collected into microcentrifuge tubes and lysed by adding ice-cold lysis buffer (20 mM Tris pH 7.5, 200 mM NaCl, 0.25% Nonidet P-40; 400 mul/100 mg of tissue sections) containing 1 mM sodium orthovanadate, 10 mM sodium fluoride, and 1 mM phenylmethylsulfonyl fluoride. Tissue culture cells were collected and processed as described previously [46].
###end p 23
###begin p 24
###xml 556 558 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
After 15 min on ice, the tissue and cell lysates were sonicated using a SonicatorTM Cell Disruptor (Heat Systems-Ultrasonic, Inc., Plainview, NY) for 5 seconds, and centrifuged at 11000 x g for 20 min at 4degreesC. Supernatants were stored at -80degreesC. For western blot analysis, protein concentrations were determined by Bradford assay (Bio-Rad, Hercules, CA). Equal amounts of unboiled protein (60 mug) were loaded onto reducing 10% SDS-Tris-glycine polyacrylamide gels, transferred to nitrocellulose (Bio-Rad), and processed as described previously [51], with some modifications.
###end p 24
###begin p 25
###xml 478 483 <span type="species:ncbi:10090">mouse</span>
###xml 489 492 <span type="species:ncbi:10116">rat</span>
Briefly, membranes were washed in Tris-buffered saline containing 0.05% Tween 20 (TBST) and non-specific binding sites were blocked by immersing the membrane in blocking reagent (0.5% casein in TBST) for 1 hour at room temperature on an orbital shaker. After blocking, the membranes were briefly rinsed in two changes of TBST, and washed once for 15 minutes and twice for 5 minutes in fresh changes of TBST. The membranes were subjected to overnight incubation (4degreesC) with mouse anti-rat LHR monoclonal antibody in blocking reagent.
###end p 25
###begin p 26
###xml 85 89 <span type="species:ncbi:9925">goat</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 291 294 <span type="species:ncbi:10116">rat</span>
The membranes were washed and incubated with peroxidase labeled secondary antibody - goat anti-mouse IgG and IgM (Jackson Immunoresearch, West Grove, PA) diluted 1:2000 - for 1 hour at room temperature. Before staining, the secondary antibody was diluted 1:60 (5 mul/300 mul), absorbed with rat kidney homogenate (150 mg/300 mul) for 20 min, centrifuged and diluted 1:2000 to the final concentration. This absorption eliminated any non-specific background. After incubation, the membranes were washed 1 x 15 min, 2 x 10 min and 4 x 5 min in fresh changes of TBST, and incubated for 1 hour in blocking buffer at room temperature. Bound antibodies were detected by a chemiluminescent detection system (ECL; Amersham Pharmacia Biotech, Piscataway, NJ) as recommended by the manufacturer's protocol. For exposure (1 min, 5 min, and up to 1 h) we used Kodak XAR film (Eastman Kodak, Rochester, NY).
###end p 26
###begin p 27
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
For protein load control, the membranes were reprobed with actin mouse mAb, clone C4 (Boehringer Mannheim Corp., Indianapolis, IN) at 0.25 mug/ml, and developed as above.
###end p 27
###begin title 28
Absorption studies
###end title 28
###begin p 29
We also included absorption studies with porcine ovarian homogenates. Primary antibody (100 mug) in 2 ml PBS was incubated 20 min with 500 mg of porcine ovarian homogenate (late follicular phase) at room temperature. After centrifugation (11000 x g for 10 min at 4degreesC), the supernatant was diluted to 10 ml with blocking reagent and used for immunostaining of nitrocellulose membranes.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 20 21 20 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat tissues (Figure 1)
###end title 31
###begin p 32
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 185 186 185 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 395 396 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 498 499 498 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 22 25 <span type="species:ncbi:10116">rat</span>
###xml 508 511 <span type="species:ncbi:10116">rat</span>
LHR expression in the rat ovaries and uterus. A) Strong LHR immunoreactivity is apparent in mature (MCL) and regressing CL (RCL) and interstitial cells (i). Note unstained vessels (v). B) Strong staining of theca interna (t) and weaker staining of mature granulosa cells (mg) in preovulatory follicle. Note scarce cytoplasmic granules with LHR immunoreactivity in immature granulosa cells (ig). C) Control. D) Increased staining during granulosa cell differentiation (dg) in large antral follicle. E) In the rat uterus, the LHR immunostaining is apparent in the surface epithelium (se), uterine glands (ug) and vasculature (v). Uterine stromal cells show nuclear staining (arrowhead). No hematoxylin counterstain.
###end p 32
###begin p 33
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 3 6 <span type="species:ncbi:10116">rat</span>
In rat ovaries, the LHR immunoreactivity was detected in the mature and regressing CL (MCL and RCL, Fig. 1A) and ovarian interstitial cells (i), follicular theca interna (t, Fig. 1B), and mature granulosa cells (mg, Fig. 1B vs. control, 1C). Note a lack of immunoreactivity in ovarian vessels (v, Fig. 1A). The antibody also identified granular cytoplasmic LHR immunoreactivity in immature granulosa cells (ig, Fig. 1B) of preantral and early antral follicles, suggestive of early LHR synthesis. This may represent synthesis of a receptor extracellular domain not yet associated with the cell surface, but remaining trapped intracellularly [18].
###end p 33
###begin p 34
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 266 269 <span type="species:ncbi:10116">rat</span>
Maturation of preovulatory follicles was associated with a transition of scarce granular cytoplasmic LHR immunoreactivity (ig, Fig. 1D) to LHR accumulation in more differentiated granulosa cells (dg). LHR immunoreactivity was also found in surface epithelium of the rat uterine cavity, epithelium of uterine glands (se and ug, Fig. 1E), nuclei of stromal cells (arrowhead), and in uterine vessels (v). The latter contrasted with a lack of staining of ovarian vessels (see above).
###end p 34
###begin title 35
###xml 22 23 22 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tissues (Figure 2)
###end title 35
###begin p 36
###xml 38 39 38 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 180 181 180 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 311 312 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 347 348 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 417 418 417 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 531 532 531 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 635 636 635 636 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 766 767 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 929 930 929 930 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Reactivity of 3B5 with human tissues. A) Dominant follicle (DOF, midfollicular phase) - g, granulosa; vl, vascular layer; ti, theca interna; tv, thecal vessels; te, theca externa. B) Fresh CL - gl, granulosa lutein cells; tl, theca lutein cells; v, proliferating luteal vessels. C) Mature CL - midluteal phase. D) Old CL (OCL, late luteal phase). E) Regressing CL (RCL, mid-follicular phase of the subsequent cycle). F) Corpus luteum of pregnancy (CLP, 3rd month of pregnancy) Arrowhead indicates cytoplasmic LHR immunoreactivity. G) Fallopian tube. Arrowhead indicates LHR immunoreactivity at the luminal aspects of epithelial cells. H) Endometrium (EM, late follicular phase - note stromal edema) - se, surface epithelium; g, glands; s, endometrial stromal cells. I) Staining of brain microvasculature (v) and microglial cells (arrowhead - see Fig. 8). Insets show control staining (ctr). Hematoxylin counterstain except panel F.
###end p 36
###begin p 37
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 233 236 <span type="species:ncbi:10116">rat</span>
During follicular selection (mid follicular phase, as determined by endometrium morphology) dominant follicles in human ovaries showed granular cytoplasmic LHR expression in granulosa cells (g, Fig. 2A), similar to those in immature rat follicles (see above). Theca interna (ti) showed more distinct LHR immunoreactivity, characterized by accumulation of LHR cytoplasmic granules. Follicular vessels (vascular layer, vl, and thecal vessels, tv) were virtually unstained. Some LHR immunoreactivity was also detected in theca externa cells (te).
###end p 37
###begin p 38
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
Early luteal development (fresh CL) was associated with very strong cytoplasmic LHR immunostaining of granulosa lutein cells migrating into the follicular cavity (gl, Fig. 2B). Adjacent theca-lutein cells (tl) also exhibited prominent staining, but showed distinct vacuolization. No LHR expression accompanied developing luteal vessels (v). In the mature CL, granulosa lutein cells showed diminution of cytoplasmic LHR immunoreactivity and strong surface staining (Fig. 2C). Luteal cells in the old CL (late luteal period) showed marked diminution of LHR expression (Fig. 2D). Regression of luteal tissue (CL investigated during the follicular phase) showed residual staining of theca-lutein cells and no staining of regressing granulosa lutein cells (Fig. 2E vs. ctr).
###end p 38
###begin p 39
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
In CL of pregnancy (CLP; 3 months), less or more distinct granular cytoplasmic LHR immunoreactivity (arrowhead, Fig. 2F vs. ctr) and no surface staining was detected. This suggests that high CG levels accompanying early pregnancy may preserve CLP through the cytoplasmic receptor. In other words, selective pick up of CG through the surface LHR expression in granulosa lutein cells during the luteal phase after conception appears not to be required if the circulating CG is very high.
###end p 39
###begin p 40
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 588 593 <span type="species:ncbi:9606">human</span>
In fallopian tubes, distinct cytoplasmic LHR expression was associated with the luminal aspect of epithelial cells (arrowhead, Fig. 2G). In endometrium (late follicular phase - note stromal edema), LHR immunoreactivity was associated with endometrial glands (g, Fig. 2H) and with the surface epithelium of the uterine cavity (se). There was also granular cytoplasmic expression in endometrial stromal cells (s), precursors of decidual cells, and similar granular staining was observed in smooth muscle cells of late follicular phase myometrium (data not shown). 3B5 antibody also stained human brain vessels (v, Fig. 2I) and showed strong LHR immunoreactivity with microglial cells (arrowhead; see Fig. 8).
###end p 40
###begin title 41
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Porcine tissues (Figure 3)
###end title 41
###begin p 42
###xml 39 42 39 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</bold>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 355 356 355 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 369 370 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 380 381 380 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 423 424 423 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 447 448 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 537 538 537 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 715 719 715 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E&#8211;J </bold>
###xml 798 801 798 801 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;D</bold>
###xml 803 805 803 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H </bold>
###xml 809 810 809 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
LHR immunostaining in porcine tissues. A-C) Preovulatory follicles (late follicular phase) show a transition from granular cytoplasmic to surface LHR immunoreactivity in granulosa cells (arrowheads), lack of staining of vascular layer, increase of LHR staining in theca interna and extreme dilatation of follicular microvasculature (v). D) Control for C. E) Mature CL. F) Old CL. G) Ovarian surface epithelium (arrowhead). H) Fallopian tube (FT). I) Skin vessels show strong LHR immunoreactivity of the entire vascular wall (arrowhead). J) In ovarian vasculature, the LHR immunoreactivity is limited to the nuclei of some endothelial cells (arrowhead) but other components of vascular wall are unstained. Insets in E-J show control staining. Details in text. Hematoxylin counterstain except panels A-D, H and I.
###end p 42
###begin p 43
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A,3B,3C</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 905 922 905 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E,7F,7G,7H,7I,7J</xref>
###xml 612 617 <span type="species:ncbi:9606">human</span>
Porcine preovulatory follicles showed distinct LHR staining of theca interna, lack of LHR expression in vascular layer under the follicular membrane, and transition of granular cytoplasmic to surface LHR immunoreactivity in granulosa cells (Fig. 3A,3B,3C, vs. control D). Mature CL showed strong surface LHR immunoreactivity of luteal cells (Fig. 7E), and old corpora lutea showed diminution of LHR immunoexpression (Fig. 3F). Ovarian surface epithelium, the source of most ovarian tumors, was also stained (arrowhead, Fig. 3G). In porcine fallopian tube (Fig. 3H), the LHR immunostaining was similar to that in human oviduct. Strong LHR immunoreactivity in vascular walls was detected in the skin (Fig. 3I), which does not represent a classic LH/CG target. This contrasted with a lack of staining in ovarian vessels, except weak nuclear staining of endothelial cells (arrowhead, Fig. 3J). Insets in Fig. 7E,7F,7G,7H,7I,7J show the control procedure.
###end p 43
###begin p 44
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
Observations of LHR immunoreactivity in porcine tissues indicate that LHR distribution is similar to that in human tissues. They also show LHR expression in the ovarian surface epithelium (not investigated in human ovaries) and astonishing differences in vascular walls of nonclassic (strong LHR in skin vessels) and classic LHR targets (week expression in ovarian vessels) - see Ref. [40] and Discussion beneath for a role of vascular LHR expression in the LH/CG delivery.
###end p 44
###begin title 45
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 9 12 <span type="species:ncbi:10116">rat</span>
###xml 14 19 <span type="species:ncbi:9606">human</span>
Multiple rat, human and porcine LHR protein variants (Figures 4 and 5)
###end title 45
###begin p 46
###xml 25 28 <span type="species:ncbi:10116">rat</span>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Western blot analysis of rat, porcine and human tissues with 3B5. KN, kidney; Ov/P, ovary in proestrus; POF, preovulatory follicle; MCL, mature CL; RCL, regressing CL (follicular phase); FT, fallopian tube; CV, chorionic villi (term placenta); T:0, time 0 trophoblast culture; EC, early culture (24 h); LC, late culture (72 h); MC, cultured placental mesenchymal cells; FB, cultured amniotic fibroblasts; VagW, vaginal wall (epithelium, connective tissue and smooth muscle bundles); LM, levator ani muscle; LF, levator ani fascia. Details in text.
###end p 46
###begin p 47
###xml 94 95 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 185 186 185 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
3B5 absorbed with porcine ovaries (western blot control). Reactivity of 3B5 in western blots (A) diminishes after preabsorption with porcine ovaries [porcine ovary absorbed (POA) 3B5] (B). C) Actin control for protein loading. For abbreviations see Fig. 4.
###end p 47
###begin p 48
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 54 57 <span type="species:ncbi:10116">rat</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 288 291 <span type="species:ncbi:10116">rat</span>
###xml 395 398 <span type="species:ncbi:10116">rat</span>
Western blot analysis of protein extracts from normal rat ovaries and human and porcine mature CL with 3B5 antibody showed six distinct bands migrating between ~92 and ~48 kDa (lanes 2, 4 and 6, Fig. 4; see also Fig. 5A). Although weak, some LHR immunoreactivity was also detected in the rat kidney protein extract (lane 1). This observation is consistent with a lack of LHR immunoreactivity in rat kidney cryostat sections reported previously [22].
###end p 48
###begin p 49
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 40 43 <span type="species:ncbi:10116">rat</span>
Distinct LHR expression was detected in rat proestrous ovaries (lane 2, Fig. 4), which contain LHR+ CL at various stages of development and regression, and developing and mature preovulatory follicles. However, in porcine preovulatory ovaries (late follicular phase), which contain numerous preovulatory follicles but no luteal tissue, very strong LHR immunoreactivity was also detected (lane 3, Fig. 4). Regression of porcine luteal tissue (RCL; lane 5) was associated with a marked decline of LHR expression. This confirmed immunohistochemical observations.
###end p 49
###begin p 50
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human tissues, mature CL (MCL; lane 6) showed LHR bands similar to that in mature porcine CL. Very strong expression of all six LHR variants was detected in the fallopian tube (FT; lane 7), which is the site of first contact with the developing embryo secreting CG, a signal required for CL preservation.
###end p 50
###begin p 51
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 103 106 <span type="species:ncbi:10116">rat</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Placental chorionic villi (CV; lane 8) also showed six distinct bands similar to those detected in the rat, human and porcine ovaries. However, time 0 and early and late trophoblast cultures derived from the same placenta (lanes 9-11) showed additional high molecular weight LHR variants (~170 kDa), possibly LHR homodimers [19], which were barely detectable or undetectable in other tissues, including placental CV. Moreover, there were additional bands detected in trophoblast cultures (~85, 60, and 46 kDa species) and a lack of a ~52 kDa variant as compared to the luteal, FT and CV protein extracts. The 44 kDa species, probably a partially degraded form from LHR turnover [18], was observed in placental cultures (lanes 9-13) and pelvic floor compartments (lanes 14-16).
###end p 51
###begin p 52
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
We also investigated cultures of placental mesenchymal cells (MC), which are always associated with trophoblast cultures [40,41], and amniotic fibroblasts (FB). Placental mesenchymal cells showed a prominent LHR band at ~68 kDa (lane 12). Note the virtual lack of other bands characteristic of trophoblast cultures. Placental amniotic fibroblasts showed two distinct LHR bands migrating at ~59 and 48 kDa (lane 13). Similar ~59 and 48 kDa species were distinctly expressed in trophoblast cultures.
###end p 52
###begin p 53
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 611 614 <span type="species:ncbi:10116">rat</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
Western blot analysis of pelvic floor compartments showed strong expression of ~92 and 68 kDa species in protein extracts from the vaginal wall (VagW; lane 14), which consists of vaginal epithelium, longitudinal and circular smooth muscle cell bundles, and connective tissue. A less prominent band was detected at ~80 kDa. Three similar bands were also found in human levator ani muscle and fascia (lanes 15 and 16). These observations indicate that pelvic floor compartments represent potential targets for the LH/CG effect. Absorption with porcine ovaries resulted in severe diminution of 3B5 reactivity with rat, porcine and human tissues in western blots (Fig. 5B vs. 5A).
###end p 53
###begin p 54
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
Altogether, these data indicate that the 3B5 antibody identifies six LHR protein variants showing distinct expression in rat, porcine and human tissues, including human placenta, with some variants also detected in human female pelvic floor compartments.
###end p 54
###begin title 55
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human chorionic villi and placental membranes (Figure 6)
###end title 55
###begin p 56
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 276 277 276 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 452 453 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 474 475 468 469 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 526 527 520 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 605 606 599 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 617 620 611 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F&#8211;H</bold>
###xml 714 715 708 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 718 719 712 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 970 971 964 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1137 1138 1131 1132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1253 1254 1247 1248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1506 1510 1500 1504 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F&#8211;I </bold>
###xml 1520 1522 1514 1516 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M </bold>
###xml 1564 1565 1558 1559 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1571 1573 1565 1567 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 1577 1578 1571 1572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1587 1588 1581 1582 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1594 1597 1588 1591 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F&#8211;I</bold>
###xml 1627 1628 1621 1622 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
LHR immunoreactivity in chorionic villi and placental membranes. A) LHR+ mononucleated trophoblast (arrowheads) and villous vascular sinusoids (v) in normal term placentae. Note unstained syncytium (white asterisks) or sporadic LHR+ granules (black asterisk). B) Detail from (A) (turned 90degrees) shows cytotrophoblast cells merging with syncytium (full arrowheads vs. white arrowhead), followed by diminution of LHR immunoreactivity (red arrowhead). C) Villous sinusoids. D) Immature (developing) villus in normal placenta. E) Abnormal placenta (note enhanced dilatation of all sinusoids - compare with A). Panels (F-H) show staining for LHR (DAB-Ni substrate) in various placental types (see text) vs. control (I). J) Occasionally detected multilayered amniotic epithelium shows a transition from granular cytoplasmic (full arrowhead) to perinuclear (yellow arrowhead) and nuclear LHR immunoreactivity (red arrowhead). Note unstained surface cells (white arrowhead). K) Extravillous trophoblast cells (basal plate) with strong perinuclear staining (full arrowheads) variable LHR immunoreactivity in decidual cells (white arrowheads). L) Parallel section shows Thy-1+ decidual cells (white arrowhead) and unstained trophoblast cells (full arrowhead). M) Dual color immunohistochemistry: extravillous trophoblast expressing LHR (full arrowhead), decidual cells expressing both markers (white arrowhead) and decidual macrophages expressing CD68 only (red arrowhead). Hematoxylin counterstain except panels F-I and panel M (dual color immunohistochemistry). Bar in C, for B and C; bar in H, for F-I. For other panels see bar in A.
###end p 56
###begin p 57
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 190 191 190 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 342 343 342 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 619 620 619 620 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 742 743 742 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 774 776 774 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 931 932 931 932 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 951 952 951 952 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 974 975 974 975 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1067 1070 1067 1070 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G&#8211;I</bold>
###xml 1079 1081 1079 1081 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I </bold>
###xml 1103 1104 1103 1104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
LHR immunoreactivity and resident macrophages in the female pelvic floor. A) Vaginal smooth muscle (Vag SM): cytoplasmic (full arrowhead) and nuclear LHR immunoreactivity (white arrowhead). B) Vaginal connective tissue (Vag ct): fibroblast type cells (white arrowhead), rounded mesenchymal cells (full arrowhead) and vessels (red arrowhead). C) Vaginal epithelium (Vag Ep): basal (stem) cells (b), parabasal cells (full arrowhead) and intermediate cells (yellow and green arrowheads). Superficial layer (middle inset): nuclear staining (red arrowhead) and diminution of staining in the surface cells (white arrowhead). D) Levator ani fascia (LF): principal cells (fibroblasts; white arrowhead) and rounded mesenchymal cells (full arrowhead). E) Levator ani muscle (see also F for detail): mesenchymal cells among muscle fibers (full arrowhead) and muscle cell nuclei (white arrowheads). CD68 staining in vaginal connective tissue (G), levator fascia (H) and levator muscle (I). Insets indicated as ctr show control staining. No hematoxylin counterstain except panels G-I. Bar in I for all panels except E.
###end p 57
###begin p 58
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 513 514 513 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 671 672 671 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 780 781 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 830 833 830 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F&#8211;K</bold>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 953 954 953 954 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 991 992 991 992 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1046 1047 1046 1047 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1088 1089 1088 1089 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1217 1218 1217 1218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1329 1330 1329 1330 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1383 1384 1383 1384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1598 1600 1598 1600 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 1604 1605 1604 1605 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1619 1626 1619 1626 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-E, L </bold>
###xml 1630 1631 1630 1631 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1640 1641 1640 1641 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1647 1654 1647 1654 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-E, L </bold>
###xml 1658 1659 1658 1659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
###xml 810 813 <span type="species:ncbi:10116">rat</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
LHR immunostaining in the gray matter of the human brain parietal lobe. A) LHR+ microglial cells with characteristic dendritic processes (full arrowhead) and flattened nuclei (yellow arrowheads). Green arrowhead indicates unstained nerve cell. B) Area occupied by microglia (full and yellow arrowheads) contains unstained nerve cells (green arrowheads). However, area lacking microglia contains LHR+ nerve cells (red arrowheads). C) Staining for leukocyte common antigen (LCA) reveals picture similar to that in (A). Note dendritic processes of microglial cells (full arrowheads), and interaction with neuronal (red arrowhead) and other glial elements (white arrowhead). D) Anti human Thy-1 (hThy-1) shows diffuse staining of brain tissue except for the vascular endothelium (v). E) Control staining with anti-rat Thy-1 (rThy-1). F-K) Schematic drawings of interstitial (glial) cells in the human brain and differences in their nuclei (from Ref. [54]). F) Fibrous astrocytes - white matter. G) Oligodendroglial cells - satellites to nerve cells. H) Protoplasmic astrocytes - grey matter. I) Microglial cells - mesodermal origin, gray and white matter. Yellow arrowhead indicates flattened nucleus of microglial cell. J) Irregularly oval nuclei of astrocytes (full arrowhead) and oval nuclei of oligodendroglia (white arrowhead). K) Small, often flattened nuclei of microglial cells. L) CD68 staining shows flattened nucleus of microglial cell (yellow arrowhead). M) No staining was observed with CD14, a marker of monocytes and immature tissue macrophages. Hematoxylin counterstain: weak in panels A and B, moderate in C-E, L and M. Bar in M, for A-E, L and M.
###end p 58
###begin p 59
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
In normal placentae at term, the LHR immunoreactivity in mature chorionic villi was found in mononucleated cytotrophoblast cells under the syncytial layer (arrowheads, Fig 6A) and villous vascular sinusoids (v), but most of the syncytiotrophoblast was virtually unstained (white asterisks vs. black). Mononucleated trophoblast cells showed variable nuclear LHR immunoreactivity (Fig. 6B, detail from A). The most prominent nuclear staining was found in trophoblast cells merging with the syncytium (full arrowheads vs. white). The red arrowhead indicates diminution of LHR expression in the cell which joined the syncytial layer. Staining of villous sinusoids was associated with basal (abluminal) aspects of endothelial cells (arrowheads, Fig. 6C). Developing (immature) chorionic villi were occasionally observed and showed more pronounced granular cytoplasmic LHR immunoreactivity in the syncytial layer (asterisk, Fig. 6D), a feature also detected in immature granulosa cells (see above).
###end p 59
###begin p 60
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
In contrast to normal placentae, granular cytoplasmic staining of the syncytial layer dominated in some moderately abnormal placentae (asterisks, Fig. 6E), which showed mild compensatory dilatation of villous sinusoids (v) - see Ref. [52] for definition of placental abnormality. In such placentae, the LHR+ mononucleated trophoblast cells were barely detectable, as well as LHR expression in villous sinusoids (white arrowheads).
###end p 60
###begin p 61
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Differences between placental types were more obvious at lower magnification. Figure 6F (vs. control 6I), shows normal placenta with prominent LHR staining of villous sinusoids (full arrowhead) and no staining of syncytium (white asterisk). Figure 6G shows LHR immunostaining of syncytium (black asterisk) and lack of vascular LHR (white arrowhead), resembling immature chorionic villi (immature placental phenotypes, characteristic for intrauterine growth retardation and maternal diabetes [52] - note lack of dilatation of villous sinusoids). Figure 6H shows that neither surface (white asterisk) nor significant vascular LHR immunoreactivity (white arrowhead) was detected in placentae with extreme dilatation of villous sinusoids (aged placental phenotype [52]).
###end p 61
###begin p 62
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6J</xref>
In placental membranes, occasionally found multilayered amniotic epithelium showed no or fine granular cytoplasmic staining of epithelial cells adjacent to the basement membrane (full arrowhead, Fig. 6J), followed by perinuclear (yellow arrowhead) and nuclear LHR immunoexpression (red arrowhead). Cells most distant from the basement membrane showed no staining (white arrowhead).
###end p 62
###begin p 63
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6K</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6L</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6M</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 399 404 <span type="species:ncbi:9606">human</span>
Extravillous trophoblast cells in placental membranes and placental basal plate (Fig. 6K) exhibited usually perinuclear (full arrowheads) and occasionally nuclear LHR expression (data not shown). In contrast, however, nuclear or no staining was prevalent in adjacent decidual cells (white arrowheads). Fig. 6L shows a semi-parallel section stained for Thy-1 glycoprotein, a characteristic marker of human decidual cells [46]. Note Thy-1+ decidual cells (white arrowhead) and unstained extravillous trophoblast cells (full arrowhead). Dual color immunohistochemistry for LHR (brown) and CD68 (blue; Fig. 6M) indicates that LHR+ decidual cells also show expression of CD68 (white arrowhead - note brown and blue color) of decidual macrophages (red arrowhead), i.e., marker also characteristic for regressing luteal cells [40]. Note a lack of macrophages among trophoblast cells.
###end p 63
###begin title 64
###xml 21 22 21 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
Pelvic floor (Figure 7)
###end title 64
###begin p 65
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 128 133 <span type="species:ncbi:9606">women</span>
Previously documented LH-dependent relaxation of the porcine oviduct [53] raises a question if high LH levels in postmenopausal women do not contribute to the relaxation of the pelvic floor, and hence to the increased incidence of pelvic floor disorders in these females. We investigated connective tissues and muscular compartments of the pelvic floor, in order to determine cellular equivalents to LHR bands detected in western blots and possible cellular targets for the LH effect.
###end p 65
###begin p 66
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
Strong cytoplasmic and nuclear LHR immunoreactivity was found in smooth muscle cells in the vaginal wall (Fig. 7A vs. ctr). Vaginal connective tissue fibroblasts (white arrowhead, Fig. 7B) and other stromal elements (full arrowhead), as well as vaginal vessels (red arrowhead), also showed distinct LHR immunoreactivity.
###end p 66
###begin p 67
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
In vaginal epithelial layers, a model for differentiation of epithelial cells [42], basal (stem) cells were unstained (b, Fig. 7C), dense cytoplasmic staining was found in parabasal (immature) cells (full arrowhead), followed by perinuclear (yellow arrowhead) and cell surface LHR immunoreactivity (green arrowhead). Nuclear staining was found in lower superficial cells (red arrowhead in adjacent panel), and cornified superficial cells showed overall diminution of LHR immunoreactivity (white arrowhead).
###end p 67
###begin p 68
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
Additional pelvic floor structure, the levator ani fascia, was studied and exhibited nuclear LHR immunoreactivity in principal cells (fibroblasts; white arrowhead, Fig. 7D) and other mesenchymal cells with rounded nuclei (full arrowhead), most probably resident macrophages (see below). Mesenchymal cells in levator ani muscle also showed LHR immunoreactivity (full arrowheads, Fig. 7E and 7F). In addition, nuclear LHR staining was also detected in levator ani striated muscle fibers, some of which were centrally (abnormally) located in this sample (white arrowheads, Fig. 7E and 7F). Note unstained muscle vessels (v) accompanied by LHR+ stromal cells.
###end p 68
###begin p 69
###xml 55 63 55 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G,7H,7I</xref>
Distribution of resident macrophages, as shown in Fig. 7G,7H,7I, suggests that rounded mesenchymal cells showing LHR immunoreactivity in pelvic floor connective tissues might be represented by this type of cells. Note association of some resident macrophages with vasculature (v).
###end p 69
###begin p 70
These observations indicate that principal components of the pelvic floor (smooth muscle cells, fibroblasts and striated muscle fibers), which are responsible for pelvic floor integrity, are potential targets for LH/CG hormonal effects. Additional cells exhibiting LHR immunoreactivity in pelvic floor connective tissues appear to be resident macrophages.
###end p 70
###begin title 71
###xml 20 21 20 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain (Figure 8)
###end title 71
###begin p 72
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 326 331 <span type="species:ncbi:9606">human</span>
Neurodegenerative diseases, including Alzheimer's disease, also show increased incidence in aging individuals. Therefore, a question arises if the rise in LH, reflecting diminution of sex steroids, can also contribute to the initiation and progression of neurodegeneration. We studied LHR expression in the gray matter of the human parietal lobe cortex. Strong LHR immunoreactivity was associated with small cells with flattened nuclei (yellow arrowheads, Fig. 8A) and numerous spiny processes (full arrowhead). Adjacent nerve cells were unstained (green arrowheads, Fig. 8B), but distant nerve cells showed moderate staining (red arrowheads).
###end p 72
###begin p 73
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8I</xref>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F,8G,8H</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8K</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8J</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8L</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8M</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 620 625 <span type="species:ncbi:9606">human</span>
###xml 680 683 <span type="species:ncbi:10116">rat</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
Staining for the leukocyte common antigen (Fig. 8C) and observation for characteristic morphology and nuclear shape (Fig. 8I vs. 8F,8G,8H; Fig. 8K vs. 8J - adapted from Ref. [54]) as well as expression of CD68 of resident macrophages (Fig. 8L) indicate that LHR immunoreactivity in Fig. 8A identifies microglial cells of mesenchymal (mesodermal) origin. Yet, Fig. 8M indicates that these cells do not express CD14 of monocytes (and primitive tissue macrophages [42]). This suggests that they are highly differentiated dendritic type cells. Figure 8D shows diffuse expression of Thy-1 in the cortex, identified with anti-human Thy-1 antibody. Figure 8E is a control using the anti-rat Thy-1 antibody (not reacting with human tissues).
###end p 73
###begin p 74
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
These data indicate that microglial cells and some nerve cells in the gray matter of the human brain cortex may be influenced by LH/CG proteohormones. Yet, loss of gray matter from areas of the parietal and temporal lobes is the most obvious consequence of Alzheimer's disease [55,56].
###end p 74
###begin title 75
Discussion
###end title 75
###begin p 76
###xml 69 72 <span type="species:ncbi:10116">rat</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Our observations indicate that the 3B5 anti-LHR antibody reacts with rat, porcine and human tissues. In western blots, the 3B5 antibody identifies six distinct bands migrating between ~92 and 48 kDa, and this reactivity with protein extracts from all three species diminishes when the antibody is preabsorbed with porcine ovaries. We also show changes in subcellular LHR distribution during differentiation of various cell types. To our knowledge, LHR expression in fibroblasts, striated muscle cells, and microglial cells (CD68+ resident macrophages) in the central nervous system is presented for the first time. We also report tissue differences in vascular LHR expression.
###end p 76
###begin p 77
During cellular differentiation, subcellular LHR distribution changed from granular cytoplasmic to perinuclear, surface and nuclear staining; virtually no staining was detected in stem cells and most differentiated and aged cells. Yet, cell surface staining was observed only on classic LH/CG targets, granulosa and theca cells of preovulatory follicles and mature luteal cells, but also in the vaginal epithelium. This indicates that these cells are prepared for the selective accumulation of LH/CG signals from the circulation.
###end p 77
###begin p 78
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1666 1668 1666 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 367 370 <span type="species:ncbi:10116">rat</span>
There was also a striking difference in vascular LHR expression between ovaries and other tissues. In ovarian (and also striated muscle) vessels the LHR expression was virtually absent (Fig. 1A, 2A, 3J), while other tissues investigated, including uterus, brain, skin and vagina, showed distinct vascular LHR immunoreactivity. We also reported previously that in the rat the endothelial LHR expression is absent in testicular vessels, and vessels in other tissues involved in LH/CG transport into (pituitary) and from the blood (kidney) [22]. Saturation of LHR in ovarian targets may be dependent on the precise delivery of small amounts of circulating LH/CG from the blood into the extravascular space. A receptor mediated endothelial transport of hCG has been suggested to represent a model for general involvement of specific receptors in transport of other plasma proteins [57,58]. Yet, application of this theory on our data will indicate that the LH/CG will be delivered to the uterus, brain, skin and vagina rather than to the ovary. Hence, the opposite mechanism should be considered - endothelial LHR expression may suppress the transport of LH/CG from vessels to the extravascular space. The LH/CG molecule is smaller than that of albumin or IgG, i.e., proteins exhibiting ubiquitous distribution, so there is no need to enhance rather only prevent LH/CG transport to inappropriate sites. Binding of LH/CG to endothelial cells expressing LHR may prevent LH/CG transport from circulation by electrostatic forces, and the lack of endothelial LHR expression may be associated with LH/CG transport mediated by a general mechanism involved in protein exchange [40].
###end p 78
###begin p 79
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
We report that normal term placentae show virtually no LHR expression in trophoblastic syncytium while syncytium of some abnormal placentae (immature phenotypes) exhibits LHR immunoreactivity. This resembles high LHR expression in first trimester placenta [28], which is a source of high hCG levels [59]. Yet, hCG levels fall during the second trimester, and elevated maternal midtrimester hCG is associated with higher rates of maternal and neonatal complications (pregnancy-induced hypertension, preeclampsia, gestational diabetes, and perinatal death) [60-63].
###end p 79
###begin p 80
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
Hence, some abnormal term placentae appear to preserve syncytium in a younger state, accompanied by high secretion of hCG. In contrast, vascular LHR expression was detected in sinusoids of chorionic villi from normal term placentae, but was virtually absent in all abnormal placentae. If the vascular LHR expression represents a barrier for hCG transport from chorionic villi to the fetal blood (see above), lack of this barrier may cause high levels of fetal hCG resulting in perinatal morbidity and mortality [63], regardless of normal or abnormal hCG production.
###end p 80
###begin p 81
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
Western blot analysis of placental villi and trophoblast cultures indicates that cultured trophoblast cells show additional bands, including ~170 kDa species, possibly an LHR homodimer [19]. Although the ~170 kDa species persisted in late cultures, other (additional) LHR variants diminished. This suggests an activation of isolated trophoblast cells and enhanced LHR synthesis with formation of additional glycosylated LHR variants, particularly in time 0 and early cultures. When compared to chorionic villi, trophoblast cultures showed stronger ~59 and 48 kDa species, characteristic for cultured fibroblasts. Indeed, it has been reported, that differentiation of cultured trophoblast is associated with activation of accompanying fibroblasts [64].
###end p 81
###begin p 82
Early differentiation of granulosa, luteal, and other cell types expressing LHR was associated with cytoplasmic LHR immunoreactivity, reflecting receptor synthesis prior its surface expression. In addition, the CL of pregnancy, the function of which is highly dependent on CG, also showed cytoplasmic expression. Hence, it is possible that high levels of circulating LH/CG, e.g., during pregnancy and after menopause, may influence not only cells with surface LH expression, but also cells with cytoplasmic, and perhaps exclusively nuclear LHR expression (pelvic floor compartments, including striated muscle). In other words, cells lacking surface LHR may not be influenced by temporary increase of LH production during the preovulatory period of the ovarian cycle due to the "cell membrane LHR barrier," and the LH effect is probably also prevented by the "vascular LHR barrier." Yet, high CG levels during pregnancy may pass the "cell membrane barrier" and act through the cytoplasmic LHR in the CL of pregnancy and other cells with cytoplasmic expression, and such effect could be enhanced if the "vascular LHR barrier" is absent - abnormal placentae of aged phenotype and similar putative age-related vascular changes in other tissues.
###end p 82
###begin p 83
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
But the LH/CG action through the cytoplasmic/perinuclear and nuclear LHRs opens a possibility of more direct LH/CG action within the cells, which may not require a classic second messenger pathway (cyclic AMP dependent signaling mechanism) involvement, or this system can act through the intracellular LHRs. Evidence is accumulating that a number of other factors modulate the actions of gonadotropins in the ovary and testis via activation of alternative signaling pathways and via LHR protein variants, and alternative second messenger pathways for the transmission of the LHR activation effect exist, which may not include stimulation of cyclic AMP levels [65-69]. A question also arises if the nuclear LHR expression in terminally differentiated cells (e.g., striated muscle fibers) may not indicate a possibility of the direct effect of LH/CG on modulation of protein synthesis, reflecting certain effects of sex steroids on their nuclear receptors.
###end p 83
###begin p 84
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
LH/CG causes a relaxation of smooth muscle cells, which express LHR [36-38] (Fig. 7A). The data presented also indicate that additional principal cell types in the pelvic floor show LHR expression, including stromal and fascial fibroblasts and striated muscle cells. This is associated with relatively high expression of LHR protein in western blots, and a fully glycosylated ~92 kDa species in particular. Interestingly, strong ~59 and 48 kDa proteins expressed in cultured fibroblasts were not detected in pelvic floor lysates, but a distinct ~68 kDa band from mesenchymal cells was apparent. We speculate that a ~92 kDa species in the pelvic floor is a result of interaction of resident macrophages with pelvic floor fibroblasts.
###end p 84
###begin p 85
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
The hCG secreted by trophoblastic syncytium during pregnancy may play an important role in the physiologic adaptation of the body, and preparation of the pelvic floor for labor in particular. However, when compared to hCG, LH has a 10-fold higher LHR binding affinity [20]. Consequently, high LH levels after menopause may cause pathologic relaxation of the pelvic floor resulting in pelvic floor disorders.
###end p 85
###begin p 86
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 1067 1072 <span type="species:ncbi:9606">women</span>
Strong LHR expression in microglial cells in the brain cortex is of particular interest. Microglial cells are resident macrophages in the central nervous system, and LHR expression has been described in other types of human resident macrophages (ovary, decidua, endometrium and corpora lutea) [22,33]. Pathological activation of microglia has been reported in a wide range of conditions such as Alzheimer's disease, cerebral ischemia, prion diseases, multiple sclerosis, AIDS dementia, and other degenerative neurological diseases [70,71]. Some of these degenerative diseases are associated with advanced age and high levels of circulating LH. High LH levels might pass the presumptive LH barrier of brain vessels expressing LHR, or vascular LHR expression might diminish with age, as in abnormal term placentae. Yet, elevated maternal mid-trimester chorionic gonadotropin is associated with fetal cerebral blood flow redistribution and adverse perinatal outcome [63]. In addition, estrogens, which are known to cause a diminution of high LH levels in postmenopausal women, have been reported to be effective in the prevention and treatment of Alzheimer's disease [72-74]. Microglia belong among cells of the mononuclear phagocyte system [75]. Since CG increases secretion of a variety of cytokines by monocytes, and induces their inflammatory reaction and phagocytic activity [76-79], high LH levels in aging individuals may also activate resident macrophages in the central nervous system and contribute to the development of Alzheimer's disease and other inflammation-mediated neurodegenerative diseases.
###end p 86
###begin p 87
Outside of the area occupied by microglial cells in the grey matter of the cerebral cortex, weaker LHR expression was also detected in some nerve cells. This suggests that such nerve cells could be directly influenced by LH/CG proteohormones (with unknown consequences), while the nerve cells among microglial branching processes are protected from such an effect.
###end p 87
###begin title 88
Conclusion
###end title 88
###begin p 89
###xml 779 784 <span type="species:ncbi:9606">women</span>
In conclusion, our observations concur with and expand current knowledge on LHR expression in gonadal and nongonadal tissues reported by other investigators. We show that the 3B5 antibody identifies six distinct LHR protein variants in three different mammalian species. Subcellular LHR localization varies during cellular differentiation. In contrast to the theory on the role of vascular hormone receptors in preferential pick up of circulating hormones, there may be no need to enhance selective pick up rather only prevent LH/CG transport to inappropriate sites. Abnormal placental LHR expression may play a role in the development of abnormal pregnancy and fetal outcome, and expression of LHR in the pelvic floor compartments suggests that high LH levels in postmenopausal women may contribute to pelvic floor relaxation and increased incidence of pelvic floor disorders. High LH levels in aging individuals may also participate in the development of inflammation-mediated neurodegenerative diseases, including Alzheimer's disease.
###end p 89
###begin title 90
Acknowledgment
###end title 90
###begin p 91
###xml 198 203 <span type="species:ncbi:9606">Child</span>
Supported by Physician's Medical Education and Research Foundation grants No. 93051 and 93066, Knoxville, Tennessee, to A.B. We thank Dr. John F. Fabre and Dr. Rosemarie Dalchau of the Institute of Child Health, London, UK, and Dr Alan F. Williams, University of Oxford, Oxford, UK, for generous gift of F10-89-4, F15-42-01 and OX-7 monoclonal antibodies.
###end p 91
###begin article-title 92
###xml 26 31 <span type="species:ncbi:9606">human</span>
Cloning and sequencing of human LH/hCG receptor cDNA
###end article-title 92
###begin article-title 93
Phosphorylation and glycosylation of the luteinizing hormone receptor
###end article-title 93
###begin article-title 94
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
Significance of the glycan moiety of the rat ovarian luteinizing hormone/chorionic gonadotropin (CG) receptor and human CG for receptor-hormone interaction
###end article-title 94
###begin article-title 95
###xml 25 30 <span type="species:ncbi:9606">human</span>
The primate placenta and human chorionic gonadotropin
###end article-title 95
###begin article-title 96
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Functional glycosylation sites of the rat luteinizing hormone receptor required for ligand binding
###end article-title 96
###begin article-title 97
Posttranslational modifications of the lutropin receptor: mass spectrometric analysis
###end article-title 97
###begin article-title 98
The porcine LH/hCG receptor, characterization and purification
###end article-title 98
###begin article-title 99
###xml 40 45 <span type="species:ncbi:9606">human</span>
The porcine ovarian luteinizing hormone/human chorionic gonadotropin receptor II. Is the purified receptor an oligomer of identical subunits?
###end article-title 99
###begin article-title 100
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Purification and partial characterization of rat ovarian lutropin receptor
###end article-title 100
###begin article-title 101
###xml 20 23 <span type="species:ncbi:10116">rat</span>
Characterization of rat ovarian lutropin receptor. Role of thiol groups in receptor association
###end article-title 101
###begin article-title 102
###xml 41 46 <span type="species:ncbi:9606">human</span>
Purification and characterization of the human ovarian LH/hCG receptor and comparison of the properties of mammalian LH/hCG receptors
###end article-title 102
###begin article-title 103
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 167 170 <span type="species:ncbi:10116">rat</span>
Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Human chorionic gonadotrophin (CG)-induced down-regulation of the rat luteal LH/CG receptor results in part from the down-regulation of its synthesis, involving increased alternative processing of the primary transcript
###end article-title 104
###begin article-title 105
###xml 91 94 <span type="species:ncbi:10116">rat</span>
Expression and functionality of luteinizing hormone/chorionic gonadotropin receptor in the rat prostate
###end article-title 105
###begin article-title 106
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Novel expression of luteinizing hormone/chorionic gonadotropin receptor gene in rat prostates
###end article-title 106
###begin article-title 107
###xml 54 57 <span type="species:ncbi:9823">pig</span>
Oestrogen-dependent expression of LH/hCG receptors in pig Fallopian tube and their role in relaxation of the oviduct
###end article-title 107
###begin article-title 108
Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor
###end article-title 108
###begin article-title 109
Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells
###end article-title 109
###begin article-title 110
###xml 63 66 <span type="species:ncbi:10116">rat</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Purification, characterization, and amino-terminal sequence of rat ovarian receptor for luteinizing hormone/human choriogonadotropin
###end article-title 110
###begin article-title 111
Structural features of mammalian gonadotropins
###end article-title 111
###begin article-title 112
###xml 53 58 <span type="species:ncbi:9606">human</span>
Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies
###end article-title 112
###begin article-title 113
###xml 138 142 <span type="species:ncbi:10116">rats</span>
Cellular localization of luteinizing hormone receptor immunoreactivity in the ovaries of immature, gonadotropin-primed and normal cycling rats
###end article-title 113
###begin article-title 114
###xml 134 137 <span type="species:ncbi:10116">rat</span>
Immunolocalization of transforming growth factor alpha and luteinizing hormone receptor in healthy and atretic follicles of the adult rat ovary
###end article-title 114
###begin article-title 115
###xml 59 64 <span type="species:ncbi:9606">human</span>
Immunohistochemical localization of the LH/HCG receptor in human ovary: HCG enhances cell surface expression of LH/HCG receptor on luteinizing granulosa cells in vitro
###end article-title 115
###begin article-title 116
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Postnatal androgenization induces premature aging of rat ovaries
###end article-title 116
###begin article-title 117
###xml 122 126 <span type="species:ncbi:10116">rats</span>
Changes of ovarian interstitial cell hormone receptors and behavior of resident mesenchymal cells in developing and adult rats with steroid-induced sterility
###end article-title 117
###begin article-title 118
Comparison of cellular distribution of LH receptors and steroidogenic enzymes in the porcine ovary
###end article-title 118
###begin article-title 119
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua
###end article-title 119
###begin article-title 120
###xml 20 25 <span type="species:ncbi:9606">human</span>
Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain
###end article-title 120
###begin article-title 121
###xml 19 22 <span type="species:ncbi:10116">rat</span>
Neurons from fetal rat brains contain functional luteinizing hormone/chorionic gonadotropin receptors
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human intermediate trophoblasts express chorionic gonadotropin/luteinizing hormone receptor gene
###end article-title 122
###begin article-title 123
###xml 90 93 <span type="species:ncbi:9823">pig</span>
Evidence for the presence of luteinizing hormone-chorionic gonadotrophin receptors in the pig umbilical cord
###end article-title 123
###begin article-title 124
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human macrophages contain luteinizing and chorionic gonadotropin receptors
###end article-title 124
###begin article-title 125
Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo
###end article-title 125
###begin article-title 126
Effect of estradiol and progesterone on oviductal LH-receptors and LH-dependent relaxation of the porcine oviduct
###end article-title 126
###begin article-title 127
###xml 20 25 <span type="species:ncbi:9606">human</span>
Luteinizing hormone/human chorionic gonadotropin receptors in myometrium and their role in uterine motility
###end article-title 127
###begin article-title 128
Uterine contractility decreases at the time of blastocyst transfers
###end article-title 128
###begin article-title 129
A proposed role for hCG in clinical obstetrics
###end article-title 129
###begin article-title 130
###xml 81 86 <span type="species:ncbi:9606">women</span>
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group
###end article-title 130
###begin article-title 131
###xml 132 137 <span type="species:ncbi:9606">human</span>
Is corpus luteum regression an immune-mediated event? Localization of immune system components, and luteinizing hormone receptor in human corpora lutea
###end article-title 131
###begin article-title 132
###xml 189 194 <span type="species:ncbi:9606">human</span>
Quantitative evaluation of the cell cycle-related retinoblastoma protein and localization of Thy-1 differentiation protein and macrophages during follicular development and atresia, and in human corpora lutea
###end article-title 132
###begin article-title 133
Association of mesenchymal cells and immunoglobulins with differentiating epithelial cells
###end article-title 133
###begin article-title 134
Estrogen, progesterone and androgen receptor expression in levator ani muscle and fascia
###end article-title 134
###begin article-title 135
###xml 26 31 26 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">kip1 </sup>
###xml 70 75 <span type="species:ncbi:9606">women</span>
Abnormal expression of p27kip1 protein in levator ani muscle of aging women with pelvic floor disorders - a relationship to the cellular differentiation and degeneration
###end article-title 135
###begin article-title 136
Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol
###end article-title 136
###begin article-title 137
Placental expression of estrogen receptor beta and its hormone binding variant - comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells
###end article-title 137
###begin article-title 138
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Thy-1: unusual localization and possible functional significance in lymphoid tissues
###end article-title 138
###begin article-title 139
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens
###end article-title 139
###begin article-title 140
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human leucocyte-common (LC) molecule: dissection of leukaemias using monoclonal antibodies directed against framework and restricted antigenic determinants
###end article-title 140
###begin article-title 141
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Expression of G1 cyclins and cyclin-dependent kinase-2 activity during terminal differentiation of cultured human trophoblast
###end article-title 141
###begin article-title 142
Variability of placental expression of cyclin E low molecular weight variants
###end article-title 142
###begin article-title 143
###xml 143 147 <span type="species:ncbi:9615">dogs</span>
Use of antibodies against LH receptor, 3beta-hydroxysteroid dehydrogenase and vimentin to characterize different types of testicular tumour in dogs
###end article-title 143
###begin article-title 144
Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life
###end article-title 144
###begin article-title 145
Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load
###end article-title 145
###begin article-title 146
Transport of protein hormones through the vascular endothelium
###end article-title 146
###begin article-title 147
A new function for the LH/CG receptor: transcytosis of hormone across the endothelial barrier in target organs
###end article-title 147
###begin article-title 148
###xml 19 24 <span type="species:ncbi:9606">human</span>
Differentiation in human chorionic villus cultures: hCG and HLA expression
###end article-title 148
###begin article-title 149
Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies
###end article-title 149
###begin article-title 150
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years
###end article-title 150
###begin article-title 151
###xml 33 38 <span type="species:ncbi:9606">human</span>
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia
###end article-title 151
###begin article-title 152
Elevated maternal mid-trimester chorionic gonadotropin > or = 4 MoM is associated with fetal cerebral blood flow redistribution
###end article-title 152
###begin article-title 153
Mesenchymal cells in tissue homeostasis and cancer
###end article-title 153
###begin article-title 154
###xml 137 140 <span type="species:ncbi:10116">rat</span>
Effects of LH and an LH-releasing hormone agonist on different second messenger systems in the regulation of steroidogenesis in isolated rat Leydig cells
###end article-title 154
###begin article-title 155
Luteinizing hormone (LH) drives diverse intracellular calcium second messenger signals in isolated porcine ovarian thecal cells: preferential recruitment of intracellular Ca2+ oscillatory cells by higher concentrations of LH
###end article-title 155
###begin article-title 156
Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty
###end article-title 156
###begin article-title 157
Second messenger systems in the action of LH and oxytocin on porcine endometrial cells in vitro
###end article-title 157
###begin article-title 158
Roles of cyclic GMP in modulating ovarian functions
###end article-title 158
###begin article-title 159
Regulating factors for microglial activation
###end article-title 159
###begin article-title 160
Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention
###end article-title 160
###begin article-title 161
###xml 85 90 <span type="species:ncbi:9606">women</span>
Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women
###end article-title 161
###begin article-title 162
Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease
###end article-title 162
###begin article-title 163
Use of estrogens for the prevention and treatment of Alzheimer's disease
###end article-title 163
###begin article-title 164
###xml 18 23 <span type="species:ncbi:9606">human</span>
Antiserum against human glucose transporter 5 is highly specific for microglia among cells of the mononuclear phagocyte system
###end article-title 164
###begin article-title 165
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human choriogonadotropin (hCG) and placental lactogen (hPL) inhibit interleukin-2 (IL-2) and increase interleukin-1 beta (IL-1 beta), -6 (IL-6) and tumor necrosis factor (TNF-alpha) expression in monocyte cell cultures
###end article-title 165
###begin article-title 166
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
Human chorionic gonadotrophin: a chemoattractant for human blood monocytes, neutrophils and lymphocytes
###end article-title 166
###begin article-title 167
Role of potassium ions in monocyte-regulating effects of chorionic gonadotropin
###end article-title 167
###begin article-title 168
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system
###end article-title 168

